SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-105004
Filing Date
2024-09-10
Accepted
2024-09-10 13:15:49
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q emma-20240331.htm   iXBRL 10-Q 2339533
2 EX-10.4 emma-ex10_4.htm EX-10.4 97586
3 EX-31.1 emma-ex31_1.htm EX-31.1 11421
4 EX-31.2 emma-ex31_2.htm EX-31.2 11510
5 EX-32.1 emma-ex32_1.htm EX-32.1 9747
  Complete submission text file 0000950170-24-105004.txt   13019626

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT emma-20240331.xsd EX-101.SCH 1726963
77 EXTRACTED XBRL INSTANCE DOCUMENT emma-20240331_htm.xml XML 3175146
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 241289555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)